Revance Therapeutics Inc. (RVNC) Slipped -6.57% or -0.83 To Price $11.8 On Monday


Revance Therapeutics Inc. (RVNC) slipped -6.57% or -0.83 to $11.8. It is close to 81896 shares traded, which is 24.81% compare to the average total volume 330091. The market cap of RVNC is $519.28 million. The year to date change is -41.84%. The 52 week price range is from $10.51 to $32.45. Price of RVNC have changed -7.20% during last week. It have changed -12.47% over last month, -29.04% over last 3 months, -44.16% over last 6 months and -56.67% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RVNC is 14.76. It is 25.08% above current price. The 200-day Moving Averages for RVNC is 20.58. It is 74.41% above current price. The 52-week High is 32.45. It is 175.00% from the current price. The 52-week Low is 10.51. It is -10.93% from current price.

There are some statistics of RVNC. It is has market cap $519.28 million. The share outstanding is 44.01 million. The average volume is 330091. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RVNC is -70.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RVNC is -55.97%.


Tags:

Share this post